| 产品名称： | Byssochlamys fulva Olliver et Smith |
|---|---|
| 商品货号： | TS205952 |
| Strain Designations： | NRRL 2975 CBS 604.71 |
| Alternate State： | Paecilomyces fulvus Stolk et Samson |
| Application： | Produces antiviral antibiotic |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | freeze-dried |
| Storage Conditions： | Frozen: -80°C or colder Freeze-Dried: 2°C to 8°C Live Culture: See Propagation Section |
| Type Strain： | yes (type strain of Paecilomyces todicus) |
| Preceptrol®： | no |
| Medium： | ATCC® Medium 312: Czapeks agar ATCC® Medium 323: Malt agar medium ATCC® Medium 336: Potato dextrose agar (PDA) |
| Growth Conditions： | Temperature: 28°C to 30°C Atmosphere: Typical aerobic |
| Name of Depositor： | NRRL |
| References： | Sokoloff B, Toda Y. Antivirus antibiotic from Paecilomyces todicus and method of producing same. US Patent 3,303,094 dated Feb 7 1967 Stolk AC, Samson RA. Studies on Talaromyces and related genera. I. Hamigera gen. nov. and Byssochlamys. Persoonia 6: 341-357, 1971. Samson RA, et al. Polyphasic taxonomy of the heat resistant ascomycete genus Byssochlamys and its Paecilomyces anamorphs. Persoonia 22: 14-27, 2009. PubMed: 20198134 Puel O, et al. The inability of Byssochlamys fulva to produce patulin is related to absence of 6-methylsalicylic acid synthase and isoepoxydon dehydrogenase genes. Int. J. Food Microbiol. 115: 131-139, 2007. PubMed: 17169453 type strain of Paecilomyces todicus |
产品中心 Product Center
联系我们CONTACT US
-
0574-87917803
24小时服务热线 -
testobio@163.com
销售邮箱 -
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址
联系方式
-
章丽敏
17757489010 -
朱静
18067106081 -
李晴
18067408036 -
李晶晶
13375187189 -
周雪
13372109301
| 产品名称： | Byssochlamys fulva Olliver et Smith |
|---|---|
| 商品货号： | TS205952 |
| Strain Designations： | NRRL 2975 CBS 604.71 |
| Alternate State： | Paecilomyces fulvus Stolk et Samson |
| Application： | Produces antiviral antibiotic |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | freeze-dried |
| Storage Conditions： | Frozen: -80°C or colder Freeze-Dried: 2°C to 8°C Live Culture: See Propagation Section |
| Type Strain： | yes (type strain of Paecilomyces todicus) |
| Preceptrol®： | no |
| Medium： | ATCC® Medium 312: Czapeks agar ATCC® Medium 323: Malt agar medium ATCC® Medium 336: Potato dextrose agar (PDA) |
| Growth Conditions： | Temperature: 28°C to 30°C Atmosphere: Typical aerobic |
| Name of Depositor： | NRRL |
| References： | Sokoloff B, Toda Y. Antivirus antibiotic from Paecilomyces todicus and method of producing same. US Patent 3,303,094 dated Feb 7 1967 Stolk AC, Samson RA. Studies on Talaromyces and related genera. I. Hamigera gen. nov. and Byssochlamys. Persoonia 6: 341-357, 1971. Samson RA, et al. Polyphasic taxonomy of the heat resistant ascomycete genus Byssochlamys and its Paecilomyces anamorphs. Persoonia 22: 14-27, 2009. PubMed: 20198134 Puel O, et al. The inability of Byssochlamys fulva to produce patulin is related to absence of 6-methylsalicylic acid synthase and isoepoxydon dehydrogenase genes. Int. J. Food Microbiol. 115: 131-139, 2007. PubMed: 17169453 type strain of Paecilomyces todicus |
